Home
Products
Products
Australian Unit Trusts (AUT)

Australian Unit Trusts (AUT)

All asset classes

Equity

Fixed Income
Strategies

Strategies

All asset classes

Equity

Fixed Income
Featured products

Featured products

Global Focused Growth Equity

Global High Income Bond

Global Impact Equity Strategy
Capabilities
Capabilities
Equity

Fixed Income

Multi-Asset
ESG
ESG
ESG overview

ESG overview

ESG at T. Rowe Price

Global Impact Equity
ESG reports

ESG reports

ESG Investing Annual Report

Sustainability Report

Global Impact Equity Annual Report

Global Impact Credit Annual Report
Policies, voting & featured contents

Policies, voting & featured contents

Our climate approach

Policies

Proxy voting & case studies
You might be interested in

2023 ESG Investing Annual Report

How ESG impacts our investment decisions

2023 Sustainability Report

How ESG impacts our corporate actions
Insights
Insights
LATEST INSIGHTS

LATEST INSIGHTS

Explore all insights
Thematic

Thematic

Global Fixed Income

ESG

Impact Investing
Featured

Featured

2025 Global Market Outlook

The Angle Podcast Link opens in new window
You might be interested in

Tech Tour 2025: AI Forever

Portfolio managers Dom Rizzo and Tony Wang, and portfolio specialist Jennifer Martin, reveal the highlights from the annual Tech Tour.

What if GLP-1 drugs disrupt your favourite takeaway?

New diabetes and obesity drugs are having a disruptive impact, not just across health care but also a range of other sectors and industries.
About
About
Global story

Regional story

Contact us

My Account My Account

My Account My Dashboard

Sign Out

My Account My Account

My Account My Dashboard

Sign Out

My Account My Account

My Account My Dashboard Client Reports

Sign Out

Your location and language

New Zealand

English

Sign Out

Home
Products
Products
Australian Unit Trusts (AUT)

Australian Unit Trusts (AUT)

All asset classes

Equity

Fixed Income
Strategies

Strategies

All asset classes

Equity

Fixed Income
Featured products

Featured products

Global Focused Growth Equity

Global High Income Bond

Global Impact Equity Strategy
Capabilities
Capabilities
Equity

Fixed Income

Multi-Asset
ESG
ESG
ESG overview

ESG overview

ESG at T. Rowe Price

Global Impact Equity
ESG reports

ESG reports

ESG Investing Annual Report

Sustainability Report

Global Impact Equity Annual Report

Global Impact Credit Annual Report
Policies, voting & featured contents

Policies, voting & featured contents

Our climate approach

Policies

Proxy voting & case studies
You might be interested in

2023 ESG Investing Annual Report

How ESG impacts our investment decisions

2023 Sustainability Report

How ESG impacts our corporate actions
Insights
Insights
LATEST INSIGHTS

LATEST INSIGHTS

Explore all insights
Thematic

Thematic

Global Fixed Income

ESG

Impact Investing
Featured

Featured

2025 Global Market Outlook

The Angle Podcast Link opens in new window
You might be interested in

Tech Tour 2025: AI Forever

Portfolio managers Dom Rizzo and Tony Wang, and portfolio specialist Jennifer Martin, reveal the highlights from the annual Tech Tour.

What if GLP-1 drugs disrupt your favourite takeaway?

New diabetes and obesity drugs are having a disruptive impact, not just across health care but also a range of other sectors and industries.
About
About
Global story

Regional story

Contact us

Choose your location

Current selection

New Zealand

English

Americas (2)

Canada

English

United States

English

Asia Pacific (3)

Asia Regional

English

Australia

English

New Zealand

English

Europe (20)

Austria

English

Belgium

English

Denmark

English

Estonia

English

Finland

English

France

English

Germany

English Deutsch

Iceland

English

Ireland

English

Italy

English

Latvia

English

Lithuania

English

Luxembourg

English

Netherlands

English

Norway

English

Portugal

English

Spain

English

Sweden

English

Switzerland

English

United Kingdom

English

Sign In or Register

Institutional Investors

Subscribe to our content and view our Insights articles.

Institutional Consultants

Create a custom dashboard to follow investments, receive email updates, and subscribe to Insights collections.

Sign in as:

Institutional Investor

Consultant

Email address

Not Registered?

Invest With Confidence^®

We’re driven by our purpose: To identify and actively invest in opportunities to help people thrive in an evolving world.

APAC Privacy Notice Cookie Policy Legal Information Accessibility Statement

Responsibility Careers Site Map

Manage Cookies

Important Information

This website is being furnished for general informational purposes only. The website does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

This does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. This has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

It is not intended for distribution to retail investors in any jurisdiction.The website is maintained by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. For Wholesale Investors only.

This website does not provide investment advice or recommendations. Nothing in this website shall be considered a solicitation to buy or an offer to sell a security, or any other product or service, to any person in any jurisdiction where such offer, solicitation, purchase or sale would be unlawful under the laws of such jurisdiction.

T. Rowe Price and our associates do not recommend or offer investment opportunities in any financial instrument (e.g., stocks, funds, cryptocurrency, etc.) via social media or messaging platforms.

T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are trademarks or registered trademarks of T. Rowe Price Group Inc. in the United States, European Union, and other countries. All other trademarks are the property of T. Rowe Price or their respective owners.